USSTOCK.TODAY
After-Market
Log in Sign up

Bio-Rad Laboratories Inc(BIO) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today

BIO
BIO
Bio-Rad Laboratories Inc
At close September 11 at 4:00 PM ET (Korea 9/12 05:00)
$369.32
+0.57 ▲ +0.15%
September 11 at 4:00 PM ET (Korea 9/12 05:00)
$369.32
+0.00 +0.00%
Resistance 388.69 Support 342.84 Lines drawn by AI for reference. They may be wrong. Treat them as a hint, not a forecast.

Full metrics table

C+
Fundamental health
vs. Medical Devices
How profitably the company operates. ⓘ
Top 30%
How fast earnings and revenue are growing. ⓘ
Top 65%
Whether the stock is cheap or expensive relative to fundamentals. ⓘ
Top 42%
Whether the company can weather downturns without a heavy debt burden. ⓘ
Top 53%
💰 Is this stock pricier than usual right now? ⓘ
Compared to this company's own recent 2Y (not other companies).
Very cheap
Cheap
Typical
Pricey
🔥 Very pricey
Simply put. What you pay today to own $1 of this company's yearly earnings is 45 KRW. Over the past 2Y, it usually traded around 11 KRW. Earnings have also shrunk, which lifts the multiple. One of the priciest stretches of the past 2Y.
Pricy doesn't mean bad. It means expectations are already baked in.· based on 1.5 profitable years
Index ⓘ -P/E ⓘ 44.74EPS (ttm) ⓘ 8.25Insider Own ⓘ 33.21%Shs Outstand ⓘ 21.7MPerf Week ⓘ -4.79%
Market Cap ⓘ 9.93BForward P/E ⓘ 35.69EPS next Y ⓘ 7.34%Insider Trans ⓘ -0.01%Shs Float ⓘ 17.9MPerf Month ⓘ 2%
Enterprise Value ⓘ 9.68BPEG ⓘ 8.44EPS next Q ⓘ 2.23Inst Own ⓘ 72.33%Short Float ⓘ 6.33%Perf Quarter ⓘ 26.29%
Income ⓘ 0.22BP/S ⓘ 3.83EPS this Y ⓘ -2.82%Inst Trans ⓘ -5.87%Short Ratio ⓘ 3.91Perf Half Y ⓘ 41.06%
Sales ⓘ 2.59BP/B ⓘ 1.38EPS next 5Y ⓘ 4.23%ROA ⓘ 2.17%Short Interest ⓘ 1.13MPerf YTD ⓘ 21.89%
Book/sh ⓘ 268.3P/C ⓘ 6.13EPS past 3/5Y ⓘ - -26.08%ROE ⓘ 3.11%52W High ⓘ -6.79% ($396.23)Perf Year ⓘ 29.18%
Cash/sh ⓘ 60.28P/FCF ⓘ 28.11Sales past 3/5Y ⓘ -2.68% 0.29%ROIC ⓘ 2.74%52W Low ⓘ 56.01% ($236.73)Perf 3Y ⓘ 1.82%
Dividend Est. ⓘ -EV/EBITDA ⓘ 21.85EPS Y/Y TTM ⓘ -29.25%Gross Margin ⓘ 51.86%Volatility(W/M) ⓘ 2.94% 2.9%Perf 5Y ⓘ -54.97%
Dividend TTM ⓘ -EV/Sales ⓘ 3.74Sales Y/Y TTM ⓘ 1.37%Oper. Margin ⓘ 9.08%ATR (14) ⓘ 10.48Perf 10Y ⓘ 134.18%
Dividend Ex-Date ⓘ -Quick Ratio ⓘ 2.33EPS Q/Q ⓘ 18.67%Profit Margin ⓘ 8.59%RSI (14) ⓘ 51.79Recom ⓘ 3
Dividend Gr. 3/5Y ⓘ -Current Ratio ⓘ 3.14Sales Q/Q ⓘ -0.09%SMA20 ⓘ -2.14% ($377.4)Beta ⓘ 1.07Target Price ⓘ $341.25
Payout ⓘ -Debt/Eq ⓘ 0.19Earnings ⓘ 2026/8/4SMA50 ⓘ 7.87% ($342.38)Rel Volume ⓘ 1.19Prev Close ⓘ $368.75
Employees ⓘ 7450LT Debt/Eq ⓘ 0.13EPS/Sales Surpr. ⓘ 49.92% 4.33%SMA200 ⓘ 21.76% ($303.32)Avg Volume(3M) ⓘ 0.29MPrice ⓘ $369.32
IPO ⓘ 1980/2/27Option/Short ⓘ Yes/YesTrades ⓘ 9553Volume ⓘ 344,832Change ⓘ 0.15%

Company

BIO 바이오래드BIO | NYSE | Medical Devices Details

BIO is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.

🧪 This U.S. healthcare company supplies instruments, reagents, and consumables used in life sciences research and clinical diagnostics. It operates with two main pillars: research tools such as genetic analysis and protein purification, along with clinical diagnostic products including blood testing and quality control. As a life sciences tools stock, its performance is closely tied to R&D and diagnostic demand.

Quote

Over the past 1 year, on the higher side

7% below its 1-year high.

Day low$368.69Day high$373.71
52w low$236.7352w high$396.23
Open$370.45
Volume344,832
Close$369.32
52W Range83%
C
2 of 8 metrics rate excellent
ETFs holding this stock 10 places

Multiple ETFs hold this stock

Buying this ETF gives you exposure to this stock as well.

ETFs holding this stockWeight
PRVS 0.02%
FXH 0.02%
MDEV 0.02%
HTEC 0.02%
SAEF 0.01%
Derivative ETFs· Caution: Long-term holdingAUM

Special products that amplify (leveraged) or invert this single stock. They decay quickly and are not for long-term holding.

XBI 10.6B
IBB 10.3B
FBT 2.9B
PBPH 1.0B
LABU 524M
Peer comparison Medical Devices

It ranks #4 in the industry

Based on market cap of $10B.

BIO $10B PER 44.7
ABT $176B PER 33.0
MDT $116B PER 22.4
SYK $106B PER 28.6
Reads on this stock 1 posts
투자 가이드 · 4/1 US Stock Taxes Complete Guide 2026 — Calculation Methods and Tax-Saving Strategies for Beginners
FAQ

FAQ

What kind of company is BIO?

BIO belongs to the Healthcare sector and operates in the Medical Devices industry.

What is the market cap of BIO?

The market cap of BIO is approximately $9.9B, ranking 945 within its sector.

What is the P/E ratio of BIO?

BIO has a P/E ratio of approximately 44.7x, which can be used to assess its valuation relative to the Healthcare sector average.

What is the 52-week high and low for BIO?

BIO has recorded a 52-week high of $396.23 and a low of $236.73.

Telegram KakaoTalk
Briefs · earnings · signals, first Telegram · KakaoTalk channels